Lyrica CR
- Product NDC
- 0071-1026
- 11-digit product format
- 000711026
- Labeler code
- 0071
- Product ID
- 0071-1026_df981020-42d9-41ff-b37d-3ddcbf354a86
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PREGABALIN
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Parke-Davis Div of Pfizer Inc
- Application
- NDA209501
- Marketing category
- NDA
- Marketing start
- 2018-01-01
- Marketing end
- 0000-00-00
- Substance
- PREGABALIN
- Active strength
- 83 mg/1
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0071-1026 | LYRICA CR (PREGABALIN) TABLET, FILM COATED, EXTENDED RELEASE [PARKE-DAVIS DIV OF PFIZER INC] | 15 | Legacy NDC | 20241206_2d832165-3d98-497c-84b0-2d9ae3f838f9.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0071-1026-01 | 00071102601 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0071-1026-01) | 2018-01-01 | 0000-00-00 | No | No | Current |